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Abstract
Some organochlorine pesticides (OCPs) and PCBs are
under investigation as possible risk factors for breast
cancer because of their estrogenic properties and
widespread presence in the environment. It is important
to know whether adipose tissue used by some
investigators and serum assays used by others can
provide comparable information on body burden.
Concentrations of seven OCPs or their breakdown
products as well as 14 PCB congeners were measured in
the adipose tissue and serum of 293 women enrolled as
controls in a case-control study of environmental factors
for breast cancer in Long Island, New York, a high-risk
region. Adipose OCP/PCB levels were measured using a
supercritical flwd extraction method developed by the
authors. 1,1-Dichloro-2,2-di(4-chlorophenyl)ethylene (p,p’-
DDE) was detected in all adipose and serum samples; two
chlordane derivatives, 3-hexachlorocyclohexane (a
lindane isomer) and hexachlorobenzene, were detected in
at least 92% of adipose samples. The di-ortho
hexachiorinated PCB congeners 2,4,5,2’,4’,5’-
hexachlorobiphenyl and 2,3,4,2’,4’,5’-hexachlorobiphenyl
were detected in all adipose and over 98% of serum
samples. 1,1-Dichloro-2,2-di(4-chlorophenyl)ethylene
comprised 77% of total pesticide residues in adipose and
71% in serum. 2,4,5,2’,4’,5’-Hexachlorobiphenyl
comprised 24% of adipose and 21 % of serum PCBs. The
relative concentration patterns of the 14 PCB congeners
were similar to those reported in other human studies
and were also typical of patterns reported in
environmental samples from various biota, including
mammals and birds, but differed substantially from
patterns reported in occupationally exposed workers. All
adipose-serum correlations for pesticides and most PCBs
were statistically significant. Either serum or adipose
OCPIPCB levels of a variety of environmental
organochlorine compounds may serve as useful
biomarkers of body burden.
Introduction
Measurable levels of OCPs3 and PCBs have been reported in
human and animal tissue for several decades ( 1 ). Two broad
groups of OCCs have been particularly targeted because some
members of these groups exhibit estrogenic properties in spe-
cialized assays (2).
The first group consists of OCPs and their derivatives.
These include /3-HCH (Fig. I ), which is an isomer of lindane,
a widely used environmental pest control product and scabi-
cide; the fungicide HCB; breakdown products ofthe termiticide
chlordane, i.e., trans-nonachlor and oxychlordane; as well as
p,p’-DDT and p,p’-DDE, which is the derivative of p,p’-DDT
most commonly found in the environment and in humans.
The second class of organochlorinated compounds is
PCBs. These are industrial mixtures that were widely used as
insulators in electrical equipment, as hydraulic fluids, and in
many other applications. Although their domestic manufacture
has ceased, millions of pounds still remain in actively used
equipment. Millions of additional pounds have been released
into the environment, often through careless disposal. Fig. 1
shows the generic structure of PCBs, as well as one common
PCB congener, BZ 153 [as given in the IUPAC system delin-
eated by Ballschmiter and Zell (3)].
Within the past few years, at least I 1 epidemiological
studies have assessed possible associations of the body burden
of these compounds with risk of breast cancer in women. Five
studies have used adipose tissue (4-8), five have relied on
levels measured in blood serum or plasma (9-I 3), and one
study has used both sources (14). Significant associations be-
tween p,p’-DDE and/or PCB levels and breast cancer risk have
been reported from studies that used media of either type (4, 7,
9, 13, 14), and lack of association with both adipose and blood
measurements has also been reported by various authors (5, 8,
1 1, 12). The study by Krieger et a!. ( 10) showed no overall
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Fig. 1. Chemical structures of OCPs and PCBs.
elevation in risk, but Savitz (15) has raised the possibility that
a significant association might exist within some subgroups. In
one report, breast cancer risk was unrelated to adipose levels of
p,p’-DDE or other pesticides but increased in a dose-related
fashion with adipose levels of f3-HCH (6).
A number of studies now in progress rely exclusively on
serum, whereas others use adipose tissue. To compare results of
the published studies with each other and with the results of
other studies in progress, it is important to form a judgment as
to whether serum and adipose tissue provide comparable infor-
mation about body burden when used as long-term biomarkers
of pesticide exposure. In this report, we used both serum and
adipose tissue gathered from 293 women without breast cancer
to ascertain the relative abundance of organochlorinated com-
pounds in the two media; that is, we determined which were
present in the highest concentrations, which were next highest,
and so forth. We also investigated in the same population the
correlations between adipose and serum concentrations of
OCPs and PCBs. These comparisons provide a basis for judg-
ing the suitability of organochlorine levels measured in the two
different media to represent body burden.
Materials and Methods
We have earned out a hospital-based, case-control study of
breast cancer as part of the National Cancer Institute-sponsored
Long Island Breast Cancer Study Project (16). The study used
the patient populations of the two largest hospitals on Long
Island: Long Island Jewish Medical Center, New Hyde Park,
NY, and North Shore University Hospital, Manhasset, NY.
Between October 1994 and October 1996, a total of 1033
female patients were interviewed in person by trained inter-
viewers in the presurgical testing areas of the hospitals, under
a protocol that was approved by the Institutional Review Boards of
the hospitals and of the American Health Foundation. A serum
sample was obtained from each patient during her scheduled
presurgical testing appointment. Adipose tissue was collected in
the operating room. Both serum and adipose tissue were immedi-
ately frozen after collection and kept in a hospital freezer at -20#{176}C
until ready for shipment on dry ice to the American Health Foun-
dation laboratory for analysis. All laboratory personnel were blind
to the identities of cases and controls.
Laboratory Methods. The levels of OCP/PCB in adipose tissue
were determined by a SEE method developed expressly for this
study and described by Djordjevic et a!. (17). The assay consists
of extraction oftissue by supercritical CO2. followed by extraction
with CO2 modified with 5% dichloromethane, and simultaneous in
situ removal of the bulk of fat on a partially deactivated neutral
alumina sorbent. This is followed by additional cleanup of SFE
extracts by adsorption column chromatography to remove the
remaining traces of fat and analysis by GC-ECD.
Serum levels of OCPIPCB were determined using a mod-
ification of the method of Wolff et a!. (18). A l-2-ml serum
aliquot, to which 50 l of a 25-ppb ‘y-chlordane solution was
added as internal control, was treated with I .5 ml methanol and
extracted three times with a 2.5-ml mixture of diethylether:
hexane ( 1 : 1). The combined extract is reduced to 0.5 ml under
nitrogen, chromatographed on the alumina column, and ana-
lyzed by GC-ECD.
Study Participants. A total of 362 women with pathologically
confirmed breast cancer were enrolled, of whom 54 (1 5%) had
carcinoma in situ. Two groups of controls were also enrolled:
470 women with benign breast disease and an additional 201
women who underwent surgery for conditions unrelated to the
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Final designation of study participants as cases or benign breast
disease controls was based upon pathological diagnosis as
detennined by post-discharge chart review and consultation
with the surgeon and/or pathologist.
The present analysis is based upon the first 293 control
women for whom either adipose or serum analyses have been
completed. There were 2 12 women with benign breast disease
(“benign controls”) and 81 surgical controls. There were 101
women among this group for whom both adipose and serum
assays were available, making it possible to study serum-adi-
pose correlations as well as partition coefficients. Samples were
chosen for analysis in the order received by the laboratory and
analyzed without regard to or knowledge of case or control
status.
Demographic characteristics of the 293 control women are
presented in Table 1 . The mean age at diagnosis was 50 years.
The group was highly educated, with 43% college graduates
and an additional one-fourth having some education beyond
college. The predominant religion was Catholic (52%), and the
second most frequent was Jewish (35%); 90% were white.
Long Island has been a focal point for several studies
because of its elevated breast cancer rates ( I 9), and the hospi-
tals were selected to ensure a large representation from this
area. About one-half of the women were residents of the two
New York State counties that make up Long Island, and most
of the remainder were from adjacent Queens County in New
York City.
Results
Adipose and Serum Concentrations of OCCs. Adipose 1ev-
els of pesticides and PCBs were measured in 22 1 control
women, and serum levels were measured in 173. Fig. 2 shows,
side by side, the similarity of distributions of the concentrations
of selected analytes in adipose and in serum. Table 2 displays
adipose concentrations of all 2 1 target analytes (seven pesti-
cides or their breakdown products and 14 PCB congeners) in
relation to limits of detection. Analytes were considered ob-
served if their concentrations exceeded limits of detection.
Table 2 also displays median and quartiles for observed con-
centrations. p,p’-DDE was detected in all 221 adipose samples.
All other pesticides were detected in at least 92% of samples.
The two PCB congeners, i.e., BZ 153 and BZ 138, were also
detected in all samples.
Table 3 shows the corresponding concentration distribu-
tions in serum. p,p’-DDE was detected in all serum samples
analyzed. HCB, oxychlordane, and trans-nonachlor were pres-
ent in over 97% of serum samples, whereas p,p’-DDT was
above detection limits in only 38.7% of samples. BZ 153 was
measurable in all but two serum samples.
Relative Abundance. The relative contribution of each of the
seven pesticide residues to total pesticides in both adipose
tissue and serum are shown in Table 4. p,p’-DDE was the most
abundant, comprising 77% of total pesticide residues in adipose
and 71% of total serum pesticides. The next most common
pesticides in adipose tissue were the chlordane derivatives
trans-nonachlor and oxychlordane, whereas in serum the most
abundant after p,p’-DDE was f3-HCH. The remaining pesticide
residues were present in approximately equal concentrations.
Table 5 shows the relative abundance of the 14 PCB
congeners in our study participants and as reported by several
other authors. The most common congener was the symmetri-
cal, di-ortho hexachlorinated congener BZ 153. It was present
in nearly identical proportions in adipose and serum, compris-
ing 24.3 and 20.9%, respectively. The next most abundant
congeners were BZ 74, BZ 118, BZ 138, and BZ 180, each of
which comprised at least 10% of total PCBs measured.
For comparison purposes, Table 5 also shows the relative
abundance of the same set of congeners reported in several
other reported human studies, as well as reports from environ-
mental samples collected for a variety of biota. A recent report
on adipose tissue by Hardell shows the relative contribution of
BZ 153 about the same as ours but also weighted somewhat
toward higher molecular weight congeners (20).
The two highly dissimilar columns of Table 5 (columns
4 and 5) show the congener distribution in fat and serum
reported by Wolff et a!. (21). Those data were based upon a
cohort of electrical equipment workers who were occupa-
tionally exposed to PCBs for extended periods of time,
including the week that samples were obtained. In those
workers, the lower molecular weight congener BZ 74 pre-
dominated. The clearance rate for BZ 74 is much more rapid
than for the higher molecular weight compounds like BZ 153
(22). Columns 6 and 7 show data for human adipose tissue
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Fig. 2. Frequency distrihuttons of concentrattons of p.p-t)DE. total OCPs. total PCBs. and BZ- I 53 in adipose tissue and serum of Long Island women without breast
cancer.
(23): these proportions are much closer to the present
results.
As an additional comparison. we show the congener dis-
tributions for various species of fish, aquatic birds, aquatic
mammals, oligochaetes (aquatic worms), and seston (aquatic
fine particulate living matter: Table 5). The boldface entry is the
congener with the highest coticentration among the 14 assayed.
BZ 153 was highest or nearly highest among all life forms
except minnows.
Adipose-Serum Correlations. The correlation between adi-
pose and serum concentrations is an important characteristic of
lipophilic compounds such as the organochlorines, because it
provides information about the steady-state partitioning of
these compounds between the lipid and aqueous phases. If the
concentrations in these two compartments are highly correlated,
then measurements in either serum or adipose may be regarded
as reliable indicators of body burden.
Fig. 3 shows scatterplots of serum versus adipose levels of
four compounds or groups on a logarithmic scale: p,p’-DDE.
total OCPs, BZ 153, and total PCBs. Each point on the graph
represents serum and adipose levels of one woman. The slopes
of the regression lines are sometimes called partition constants,
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Table 2 Adipose tissue concentration distributions (nglg) of 7 OCPs and 14 PCB congeners in 221 Long Island women without breast cancer
Concentration in Detection Observed” Percentile
. a . . Mean SE
adipose, ng/g limit , % 25th 50th 75th
.
Maximum
p,p’-DDE 221 0.231 221 100.0 546.7 46.6 140.3 331.5 720.8 6326.3
o,p’-DDD 221 0.463 213 96.4 19.9 1.6 9.5 13.9 22.0 277.8
p,p’-DDT 221 0.602 209 94.6 17.0 1.4 6.6 10.7 19.6 171.9
3-HCH 221 0.231 203 91.9 22.2 1.6 8.8 15.2 27.1 150.5
HCB 221 0.116 216 97.7 19.7 1.8 10.7 15.9 21.3 340.4
Oxychlordane 221 0.069 217 98.2 40.9 1.8 23.2 34.2 52.8 156.6
trans-Nonachlor 221 0.069 220 99.5 45.9 2.4 23.6 35.8 53.5 211.7
Total pesticides 22 1 707.5 5 1 .2 225.0 472.7 924. 1 6670.0
BZ 74b 221 0.579 217 98.2 30.1 1.6 14.3 23.9 40.0 146.1
BZ99 221 0.289 214 96.8 17.6 1.2 7.6 12.1 20.4 148.1
BZ I 18 221 0.434 218 98.6 33.0 2.4 12.5 22.4 38.8 279.9
BZ 138 221 0.072 221 100.0 34.7 1.9 18.0 27.2 41.6 203.0
BZ 146 221 0.072 212 95.9 8.6 0.5 4.3 6.3 10.3 38.5
BZ 153 221 0.723 221 100.0 66.2 3.2 35.9 53.9 79.1 279.9
BZ 156 221 0.231 21 1 95.5 9.1 0.4 4.7 7.2 12.3 33.0
BZ 167 221 0.072 152 68.8 1.9 0.1 0.8 1.4 2.2 8.5
BZ 170 221 0.289 216 97.7 11.9 0.5 6.6 9.8 15.3 54.2
BZ 172 221 0.072 149 67.4 2.8 0.2 1.3 2.0 3.6 16.9
BZ 178 221 0.072 187 84.6 4.1 0.3 2.0 3.1 4.8 25.3
BZ 180 221 0.723 219 99.1 32.1 1.6 16.6 26.7 41.8 178.3
BZ 183 221 0.116 198 89.6 5.7 0.4 2.7 4.2 7.0 43.6
BZ 187 221 0.174 216 97.7 15.2 0.9 7.1 11.0 19.4 117.5
TotalPCBs 221 267.0 13.1 141.8 213.9 329.0 1103.6
a Samples, the concentrations of which equal or exceed the limits of detection.
b 5e Refs. 3 or 23 for definitions of PCB congeners.
Table 3 Serum concentration distributions (ng/ml) of 7 OCPs and 14 PCB congeners in 173 Long Island women without breast cancer”
b
Concentration in Detection “ ercenti e
n . . Mean SE
serum, ng/ml limit  % 25th 50th 75th
Maximum
p,p’-DDE 173 0.028 173 100.0 4.72 0.42 1.33 3.03 6.20 46.00
o,p’-DDD 137 0.056 121 88.3 0.22 0.03 0.10 0.16 0.23 3.12
p,p’-DDT 173 0.072 67 38.7 0.22 0.02 0.1 1 0.14 0.24 1.00
-HCH 137 0.028 133 97.1 0.82 0.19 0.28 0.43 0.75 25.34
HCB 173 0.014 171 98.8 0.21 0.02 0.12 0.17 0.25 2.24
Oxychlordane 173 0.008 168 97.1 0.25 0.01 0.16 0.23 0.31 0.92
trans-Nonachlor I 73 0.008 172 99.4 0.24 0.01 0. 13 0. 19 0.28 1.48
Total pesticides 173 6.29 0.51 2.31 4.03 8.21 51.20
BZ 74C 137 0.069 132 96.4 0.37 0.02 0.21 0.31 0.46 1.39
BZ99 137 0.035 126 92.0 0.16 0.01 0.09 0.12 0.19 0.60
BZ 118 173 0.052 159 91.9 0.30 0.03 0.12 0.18 0.33 2.78
BZ 138 173 0.009 171 98.8 0.31 0.02 0.16 0.26 0.37 1.31
BZ 146 173 0.009 126 72.8 0.09 0.01 0.05 0.07 0.10 0.56
BZ 153 173 0.087 170 98.3 0.55 0.04 0.28 0.44 0.69 3.62
BZ 156 137 0.028 101 73.7 0.09 0.01 0.04 0.07 0.1 1 0.32
BZ 167 137 0.009 56 40.9 0.04 0.003 0.02 0.03 0.06 0.14
BZ17O 173 0.035 141 81.5 0.11 0.01 0.06 0.08 0.12 1.61
BZ 172 137 0.009 10 7.3 0.13 0.10 0.02 0.02 0.04 1.06
BZ 178 137 0.009 62 45.3 0.05 0.003 0.03 0.04 0.06 0.17
BZ 180 173 0.087 145 83.8 0.29 0.03 0.14 0.24 0.35 3.66
BZ 183 173 0.014 85 49.1 0.06 0.004 0.03 0.05 0.07 0.30
BZ 187 173 0.021 150 86.7 0.11 0.01 0.05 0.09 0.15 0.53
TotalPCBs 173 2.15 0.13 1.12 1.68 2.88 8.61
a Concentrations of selected analytes were not available for 36 subjects due to use of 30-m column for initial samples.
b Samples, the concentrations of which equal or exceed the limits of detection.
C See Refs. 3 or 23 for definitions of PCB congeners.
in analogy with the concept in physical chemistry of equilib- for pesticides; the partition slope for BZ 153 was 27 and for
rium established between two phases (24). These slopes, shown total PCBs was 72.
as straight lines in Fig. 3, were 131 for p,p’-DDE and I 10 for Table 6 presents the serum-adipose correlation coefficient
total pesticides. PCB partition constants were shallower than (p) for each chemical species that we measured. Values of p for
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Table 4 Mean concentration of individual pesticides in serum and adipose
tissue and the percentage each makes of total concentration
Adipose” Serum”
Pesticide Mean Mean
residue . % of all . % of all
concentration concentration
pesticides pesticides(ng/g) (ng/ml)
I-ICB 19.74 2.8 0.214 3.2
f3.HCH 22.21 3.1 0.824 12.3
Oxychlordane 40.89 5.7 0.249 3.7
trans-Nonachlor 45.90 6.4 0.236 3.5
pp-DDE 546.74 76.8 4.72 70.7
o.p’-DDD 19.85 2.8 0.218 3.3
p,p’-DDT 16.98 2.4 0.216 3.2
Total OCPs 712.30 100.0 6.677 100.0
a ,, = 221
Sn = 173.
most analytes were nearly identical whether or not samples that
contained individual OCP/PCB below limits of detection were
included. All OCP serum-adipose correlation coefficients were
statistically significant (P < 0.001 except for oxychlordane
P < 0.01). The highest correlation coefficient among the OCPs
was observed for HCB (p 0.84). For DDE (detected in 100%
of samples) p = 0.73, for -HCH (second most abundant
pesticide in serum) p 0.58, and for trans-nonachlor (second
most abundant in adipose) p = 0.66.
Significant positive serum-adipose correlation coefficients
(P < 0.05) were obtained for 10 of the 14 PCB congeners
(counting detected levels only) or for 12 of 14 (counting all
samples). Actual values of p tended to be lower for PCB
congeners than for OCPs; the highest observed was for BZ I 18
(p = 0.69). For BZ 153 (the most abundant congener), it was
p = 0.29 (P < 0.01).
Discussion
The consistent and statistically significant correlations between
serum and adipose levels of the large majority of OCP/PCBs
suggest that either medium may be used with confidence as a
biomarker of body burden of these organochlorinated compounds.
The finding of detectable but low levels of p,p’-DDE and PCBs in
all women studied is typical of human sampling studies but pro-
vides no clues to sources of exposure in individual study partici-
pants. The p,p’-DDE that we measured in our study subjects is
more likely to have resulted from ingestion of p,p’-DDE from
exogenous sources than as a metabolic end-product of past expo-
sure to the parent compound, p,p’-DDT (25). The principal source
of exposure to p,p’-DDE and other organochlonnated compounds
for most Americans is through the food chain, notably meat,
poultry, fish, and dairy products (1). p,p’-DDT has been banned
from commercial usage in the United States since 1972, but its
environmental persistence, notably as its derivative p,p’-DDE, has
given it a ubiquitous presence in animals and humans more than
two decades later.
Our ability to detect with confidence very small concentra-
tions of OCP/PCBs, especially in serum, is attributable in part to
exploitation ofanalytical methods based upon advanced chromato-
graphic technology. For instance, the first 36 serum samples that
were analyzed by GC-ECD on a 30-m fused silica capillary col-
unm did not allow for separation of 13-HCH, o,p’-DDD, or 6 of the
14 PCB congeners. Upon switching to a 60-rn column with a film
thickness of I pm, we could detect even minute amounts of these
residues; 13-HCH now had a detection limit of 0.03 ng/ml and was
observed in 97.1% of serum samples, whereas both BZ 74 and BZ
99 were detected in >90% of serum samples. By contrast, in a
recent report by Archibeque-Engle et a!. (26), only the most
abundant pesticide residue (p,p’-DDE) and PCB congeners BZ
153 and BZ 1 18 were quantified in serum. Their choice of chro-
matographic columns (either packed column or capillary column
with the lower resolution capacity), together with detection limits
1-2 orders of magnitude higher than we reported in Table 3,
prevented the assessment of the whole spectrum of serum OCP/
PCBs. Therefore, it was not surprising that Archibeque-Engle et
a!. (26) found poor or no correlation between the adipose and
serum levels of OCP/PCBs. Improved OC resolution and overall
method sensitivity for OCP/PCB assessment in both serum and
Table 5 Relative abundance of 14 PCB congeners in adipose tissue and serum of Long Island women without breast cancer in comparison with other
environmentally and occupationally exposed populations and in comparison with relative abundance reported in aquatic mammals, birds, fish, and other biota
---- . Human (%) Porpoise Carp Duck Fathead minnow Oligochaete Seston Shrimp
Fat Serum Fat Fat Serum Fat Milk #{176}“ ) ) ( (%) ) (‘k)
Reference This study 20 21 21 23 23 23 23 23 23 23 23 23
Congener”
BZ 74 1 1.0 14.1 1.8 47.2 51.1 0.0 16.7 0.0 3.2 3.7 55.2 2.6 0.0 0.0
BZ 99 6.4 6.0 2.1 7.3 7.3 2.9 7.3 5.7 0.0 0.0 15.2 0.0 10.0 21.1
BZ 118 12.1 11.3 4.8 14.5 14.6 8.2 9.9 3.6 5.8 6.9 9.0 3.8 6.7 10.6
BZ 138 12.7 1 1.6 23.7 7.3 7.3 21.2 15.2 27.1 14.1 13.5 0.0 14.2 23.3 22.5
BZ 146 3.2 3.4 0.0 1.3 0.6 4.1 2.9 0.0 3.2 3.8 0.0 2.4 0.0 0.0
BZ 153 24.3 20.9 26.6 9.1 7.3 32.6 18.2 36.5 27.0 26.7 10.5 23.8 20.0 22.5
BZ 156 3.3 3.3 2.7 3.6 2.9 3.0 7.5 0.0 0.9 1.2 1.4 0.9 0.0 0.0
BZ 167 t).7 1.5 1.1 0.9 0.6 0.7 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0
BZ 170 4.4 4.1 9.2 1.8 1.5 5.9 8.1 5.7 12.7 13.0 1.1 13.5 13.3 4.9
BZ 172 1.0 4.8 1.1 0.0 0.0 1.8 0.5 0.0 1.2 1.3 0.0 1.3 0.0 0.0
BZ 178 1.5 1.7 1.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0
BZ 180 11.8 10.8 18.3 5.4 4.4 11.7 8.1 12.2 17.1 17.6 2.9 16.8 16.7 7.0
BZ 183 2.1 2.3 3.1 0.5 0.7 1.2 2.1 2.9 5.4 5.7 0.0 7.7 3.3 0.7
BZ 187 5.6 4.3 4.0 1.1 1.5 5.3 2.3 6.5 9.5 6.7 0.0 13.0 6.7 10.6
Total’ 1000 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Most abundant” BZ 153 BZ 153 BZ 153 BZ74 BZ74 BZ 153 BZ 153 BZ 153 BZ 153 BZ 153 BZ52 BZ 153 BZ77 BZS2
a Boldface shows the congener with the highest concentration among the 14 assayed.
,, See Refs. 3 or 23 for definitions of PCB congeners.
(. Data from McFarland and Clarke (23) normalized to 100% for 14 congeners shown.
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Fig. 3. Scatter plots (log-log scale) of concentrations of pp-DDE, total OCPs.
total PCBs, and BZ-153 in adipose tissue versus serum of Long Island women
without breast cancer.
adipose tissue may prove crucial in attempts to validate previous
reports regarding the association of organochlonnated compounds
with breast cancer, especially the role of 3-HCH (6), pesticides
other than p,p’-DDE, and perhaps specific PCB congeners.
The mean serum concentration of p,p’-DDE reported in
various United States populations has clearly declined over
time. The mean level of p,p’-DDE in 50 white women who
served as controls in the Oakland cohort and whose blood was
collected during 1964-1971 was 35.0 ppb (10). It was 1 1.0 ppb
in 171 controls (80% of whom were white) in the study of
women screened in New York City during 1985-1991 (9). The
mean level in our own controls was 4.7 ppb, based on serum
that we collected in 1994-1996. This temporal decline in
human blood levels of p,p’-DDE since I 964 is almost certainly
due to the cessation of active spraying of p,p’-DDT in the
1970s. Our study documents the persistence of OCCs in Long
Island women, years after these compounds were banned from
most commercial uses in the United States.
PCBs have also been banned from domestic production since
1977 but are highly persistent in the environment even today. The
major source of ambient exposure is environmental cycling of
PCBs introduced previously into the environment. The general
population may be exposed to PCBs by inhaling contaminated air
and ingesting contaminated water and food; food consumption has
accounted for the major body burden in the past (2, 27). Compar-
ison of the distribution of congeners in the present study, which
were weighted toward high molecular weight species with data
reported for an industrial cohort by Wolifet a!. (21), who observed
more congeners of lower molecular weights, strongly supports the
hypothesis that the exposures in the women in our case-control
study were largely from environmental sources such as food and
air rather than occupational sources.
Concern has been raised that serum levels of OCCs may be
affected by hormonal or chemotherapeutic treatment for breast
cancer, and that this may in turn bias comparisons with un-
treated controls. This concern, of course, does not apply to
cohort or nested case-control studies, such as those of Krieger
et a!. (10), or Wolff et a!. (9) in which serum was obtained
Table 6 Correlation coefficients of adipose versus serum concen trations of OC Ps and selected PCB congeners
Ratio of adipose Correlation coefficient: No. of







p,p’-DDE 1 15.8 0.728 101 <0.001 0.728 101 <0.001
o,p’-DDD 91.0 0.791 67 <0.001 t).758 85 <0.0()l
p,p’-DDT 78.6 0.700 31 <0.001 0.702 101 <0.0()l
f3-HCH 27.0 0.584 78 <0.001 0.581 85 <0.001
HCB 92.2 0.841 99 <0.001 0.834 101 <0.001
Oxychlordane 164.2 0.332 97 <0.01 0.361 101 <0.001
trans-Nonachlor 194.5 0.657 99 <0.001 0.661 101 <0.001
PCBs’
BZ 74 80.5 0.305 83 <0.01 0.326 85 <0.01
BZ 99 109.8 0.524 76 <0.001 0.522 85 <0.0()l
BZ 1 18 109.9 0.688 90 <0.001 0.689 101 <0.001
BZ 138 1 12.9 0.508 100 <0.001 0.515 101 <0.0()l
BZ 146 96.8 0.318 69 <0.01 0.198 lt)l <0.05
BZ 153 1 19.5 0.271 99 <0.01 0.289 101 <0.01
BZ 156 104.3 0.203 60 NSd 0.249 85 <0.01
BZ 167 45.2 0.052 30 NS 0.280 85 <0.01
BZ 170 109.2 0.234 77 <0.05 0.296 101 <0.01
BZ 172 22.2 -0.454 6 NS -0.265 85 NS
Bz 178 90.8 -0.337 35 <0.05 t).048 85 NS
BZ 180 111.9 0.325 80 <0.01 t).354 101 <0.001
BZ 183 94.3 0.358 43 <0.05 0.343 101 <0.001
BZ 187 133.6 0.392 83 <0.001 0.386 101 <0.0()I
a Based only on samples the concentrations of which exceeded the limits of detection.
b Based on all samples.
‘. See Refs. 3 or 23 for definitions of PCB congeners.
d NS, not significant.
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months or years before development of clinical disease requir-
ing treatment. There is some evidence that this may not even be
an important problem in case-control studies. In a pilot study,
Gammon et a!. (28) found similar levels of p,p’-DDE in breast
cancer cases before and after chemotherapy. Virtually all of the
samples in the present report were obtained from patients prior
to any treatment, and many were obtained before a definitive
breast cancer diagnosis was made.
Case-control comparisons and estimation of breast cancer
risk in relation to 0CC levels in both adipose and serum are
presently under way in this population. Considerations of statisti-
cal power and relatively small differences in 0CC levels between
cases and controls underscore the need to analyze samples from
large numbers of individuals. Both case-control and cohort studies
in the past may have been limited by high costs associated with
extraction and clean-up of samples. The adipose concentrations
reported here were obtained by SFE, a technique that is more
efficient than the traditional Soxhlet extraction method and that
also has the advantage of consuming considerably smaller quan-
tities of organic reagents. A similar method has been applied
recently to analysis of PCBs by Hardell et a!. (20).
To summarize, the relative abundance ofthe OCPs and PCBs
was nearly identical in serum and adipose tissue, and the concen-
(rations of most chemical species in adipose tissue were highly
correlated with their concentrations in serum. Collection of serum
in population studies is ordinarily considered less invasive than
adipose tissue, although at least one group has shown that large-
scale adipose studies are also feasible (8, 29). Our data thus
support the assertion that either adipose or serum assays can be
useful measures of human body burden of environmental organo-
chlorinated compounds in epidemiological studies ofbreast cancer
and increase confidence that data gathered in serum-based studies
reflect body burden of OCCs in a quantitative manner suitable for
use in assessment of cancer risk.
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